Ertapenem for Infections Caused by ESBL-producing Bacteria
Background: Infections caused by extended-spectrum β-lactamase (ESBL)–producing gram-negative organisms are a growing concern in hospitalized patients. Traditionally, these infections can be ...
Hypermucoviscous K pneumoniae Shows Reduced Drug …
2025年1月7日 · Hypermucoviscous Klebsiella pneumoniae (hmKp) strains demonstrate a significantly lower prevalence of extended-spectrum beta-lactamase (ESBL) production and slightly lower carbapenem resistance ...
Doripenem: A New Carbapenem Antibiotic - Medscape
Doripenem, a member of the β-lactam class of antibiotics, is the newest addition to the carbapenems. ... particularly extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, P ...
Pathogen-associated Skin and Skin-structure Infections: Antibiotics ...
Among other Gram-negative species, ESBL is cause for concern, having been isolated in approximately 7.1% of E. coli and 11.3% of Klebsiella species causing cSSSI.
Ertapenem for Infections Caused by ESBL-producing Bacteria
Existing data on the use of ertapenem for treatment of infections caused by ESBL-producing gram-negative bacteria are fairly limited; only 3 case series and 1 small prospective trial have been ...
Pathogen-associated Skin and Skin-structure Infections: Antibiotics ...
English Edition. Medscape. English; Deutsch; Español; Français; Português; Univadis
Economics of Antibiotic Resistance - Medscape
Antibiotics are developed to kill microorganisms; however, microorganisms develop and disseminate resistance as a reaction to antimicrobials in accordance with the laws of evolution and natural ...
Travelers' Antibiotic Use May Foster Drug-Resistant Bacteria
2015年1月28日 · ESBL-PE colonization occurred in 11% of those without TD or antibiotic use, in 21% of those with TD without antibiotic use, and in 37% of those with TD treated with antibiotics.
Ascites and Spontaneous Bacterial Peritonitis: An Asian
Microorganisms that are resistant to antibiotics, such as those possessing extended-spectrum beta-lactamase (ESBL), are becoming a clinical problem in managing SBP.
Pathogen-associated Skin and Skin-structure Infections: Antibiotics ...
Findings of several studies include significant associations of ESBL-producing Enterobacteriaceae with fluoroquinolones and third-generation cephalosporin use as well as MDR-P. aeruginosa ...